Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
Clinical trial NCT05413304 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05413304
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-07
- Primary completion
- 2025-10-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.